Discovery and structural optimization of 4-(4-(benzyloxy)phenyl)-3,4-dihydropyrimidin-2(1H)-ones as RORc inverse agonists
Crossref DOI link: https://doi.org/10.1038/aps.2016.32
Published Online: 2016-07-04
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wu, Xi-shan
Wang, Rui
Xing, Yan-li
Xue, Xiao-qian
Zhang, Yan
Lu, Yong-zhi
Song, Yu
Luo, Xiao-yu
Wu, Chun
Zhou, Yu-lai
Jiang, Jian-qin
Xu, Yong
Text and Data Mining valid from 2016-07-04
Article History
Received: 16 March 2016
Accepted: 5 April 2016
First Online: 4 July 2016